Literature DB >> 8969791

Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study.

D Liao1, L Cooper, J Cai, J F Toole, N R Bryan, R G Hutchinson, H A Tyroler.   

Abstract

BACKGROUND AND
PURPOSE: White matter lesions (WML) may result from cerebral hypoperfusion or ischemia. We investigated the association of WML with blood pressure, hypertension, and its treatment and control.
METHODS: A random sample of 1920 participants aged 55 to 72 years in the Atherosclerosis Risk in Communities Study (ARIC) was examined. Spin-density 1.5-T MRI scan images were coded from 0 for normal to 9 for most severe WML. Hypertension was defined as systolic or diastolic pressure > or = 140/90 mm Hg or use of antihypertensive medication.
RESULTS: The percentages of persons with WML grades 0 through 2 and 3 through 9, respectively, were as follow: normotensive, 92.4% and 7.6%, versus all hypertensive subjects, 83% and 17% (P < .001); and treated controlled hypertensive, 86% and 14%, versus treated uncontrolled hypertensive subjects, 76% and 24% (P = .003). Multivariable adjusted odds ratios (95% confidence intervals) for WML grade > or = 3 relative to normotensive subjects was 2.34 (1.71 to 3.20) for all hypertensives, 1.99 (1.19 to 3.08) for untreated hypertensives, 1.94 (1.32 to 2.85) for treated controlled hypertensives, and 3.40 (2.30 to 5.03) for treated uncontrolled hypertensives. After additional adjustment for hypertension duration, treatment, and control status, the odds ratios (95% confidence intervals) for a 1 SD increase of systolic and diastolic blood pressure were 1.43 (1.11 to 1.85) and 1.16 (0.94 to 1.43), respectively.
CONCLUSIONS: Hypertension is associated with increased odds of WML, and treated uncontrolled hypertensive subjects have greater odds of WML than those with treated controlled hypertension. The data suggest that the level of blood pressure, especially systolic blood pressure, is related to WML, additional to the effects of categorically defined hypertension and its treatment and control status.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8969791     DOI: 10.1161/01.str.27.12.2262

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  121 in total

Review 1.  Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease.

Authors:  Oscar L Lopez; James T Becker; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  D C Bezerra; A R Sharrett; K Matsushita; R F Gottesman; D Shibata; T H Mosley; J Coresh; M Szklo; M S Carvalho; E Selvin
Journal:  Neurology       Date:  2011-12-14       Impact factor: 9.910

3.  [New guidelines for treatment of hypertension].

Authors:  H Haller
Journal:  Internist (Berl)       Date:  2005-05       Impact factor: 0.743

4.  Age-related signal intensity changes in the corpus callosum: assessment with three orthogonal FLAIR images.

Authors:  Akira Yamamoto; Yukio Miki; Hidekazu Tomimoto; Mitsunori Kanagaki; Takahiro Takahashi; Yasutaka Fushimi; Junya Konishi; Tabassum Laz Haque; Kaori Togashi
Journal:  Eur Radiol       Date:  2005-04-26       Impact factor: 5.315

5.  Treatment of leukoaraiosis.

Authors:  Gary L Schwartz; Myriam Fornage; Thomas Mosley; Stephen T Turner
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

Review 6.  Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

Authors:  Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  Association of hospitalization with long-term cognitive and brain MRI changes in the ARIC cohort.

Authors:  Charles H Brown; A Richey Sharrett; Josef Coresh; Andrea L C Schneider; Alvaro Alonso; David S Knopman; Thomas H Mosley; Rebecca F Gottesman
Journal:  Neurology       Date:  2015-03-11       Impact factor: 9.910

8.  Anemia is associated with the progression of white matter disease in older adults with high blood pressure: the cardiovascular health study.

Authors:  Marco Inzitari; Stephanie Studenski; Caterina Rosano; Neil A Zakai; William T Longstreth; Mary Cushman; Anne B Newman
Journal:  J Am Geriatr Soc       Date:  2008-09-22       Impact factor: 5.562

9.  Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study.

Authors:  Andrew M Demchuk; Firosh Khan; Michael D Hill; Philip A Barber; Brian Silver; Suresh Patel; Steven R Levine
Journal:  Cerebrovasc Dis       Date:  2008-06-17       Impact factor: 2.762

10.  White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?

Authors:  Frank A Provenzano; Jordan Muraskin; Giuseppe Tosto; Atul Narkhede; Ben T Wasserman; Erica Y Griffith; Vanessa A Guzman; Irene B Meier; Molly E Zimmerman; Adam M Brickman
Journal:  JAMA Neurol       Date:  2013-04       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.